The novel class of GLP-1 agonist medication and GIP combined medications, such as tirzepatide, semaglutide, and the relatively introduced retatrutide, offer significant progress in diabetes treatment . https://peptidescience317227.brainyblogger.com/62094914/tirzepatide-the-comparative-examination